Illumina’s global headquarters in San Diego. REUTERS/Mike Blake Illumina Inc. (NASDAQ: ILMN) is presenting new research at the American Society of Clinical Oncology annual meeting, which began Friday in Chicago. Highlights include data from several studies in partnership with Labcorp, a leader in comprehensive laboratory services and research and the Sarah Cannon Research Institute in Nashville demonstrating further evidence to support the use of comprehensive genomic profiling over single-gene testing. “We’re committed to delivering impactful research to help enable genomic testing in oncology care,” said Pratheesh Sathyan, head of Oncology for the Americas region at Illumina in
Hence then, the article about illumina presents research to boost case for genomic testing in oncology care was published today ( ) and is available onTimes of San Diego ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Illumina Presents Research to Boost Case for Genomic Testing in Oncology Care )